CY1105347T1 - Η χρηση της προπιονυλο l-καρνιτινης ή ενος απο τα φαρμακολογικα αποδεκτα αλατα της για την παρασκευη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της νοσου του peyronie - Google Patents
Η χρηση της προπιονυλο l-καρνιτινης ή ενος απο τα φαρμακολογικα αποδεκτα αλατα της για την παρασκευη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της νοσου του peyronieInfo
- Publication number
- CY1105347T1 CY1105347T1 CY20061100685T CY061100685T CY1105347T1 CY 1105347 T1 CY1105347 T1 CY 1105347T1 CY 20061100685 T CY20061100685 T CY 20061100685T CY 061100685 T CY061100685 T CY 061100685T CY 1105347 T1 CY1105347 T1 CY 1105347T1
- Authority
- CY
- Cyprus
- Prior art keywords
- carnitine
- propionyl
- peyronie
- disease
- preparation
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 5
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 title abstract 4
- 208000004362 Penile Induration Diseases 0.000 title abstract 3
- 208000020758 Peyronie disease Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 229960001722 verapamil Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η εφεύρεση που περιγράφεται στην παρούσα αφορά στη χρήση της προπιονυλο L-καρνιτίνης ή ενός εκ των αλάτων της για την παρασκευή ενός φαρμάκου το οποίο είναι χρήσιμο στη θεραπευτική αντιμετώπιση της νόσου του Peyronie στα διάφορα στάδια αυτής, ιδιαίτερα στο προχωρημένο στάδιο και σε μορφές οι οποίες είναι ανθεκτικές σε συμβατικές θεραπείες. Το φάρμακο είναι κατάλληλο για την από του στόματος, την ενδομυϊκή, την ενδοφλέβια και την ενδοπλακική χορήγηση. Η εφεύρεση που περιγράφεται στην παρούσα αφορά επίσης σε ένα συνδυασμό ενός δραστικού συστατικού στη θεραπευτική αντιμετώπιση της νόσου του Peyronie, ειδικότερα της βεραπαμίλης και της προπιονυλο L-καρνιτίνης ή ενός από τα φαρμακευτικά αποδεκτά άλατα της. Η προπιονυλο L-καρνιτίνη αποδείχτηκε πιο αποτελεσματική σε σχέση με τα γνωστά δραστικά συστατικά, ακόμη και σε ανθεκτικές στη θεραπεία μορφές, και εμφανίζει χαμηλότερη εμφάνιση παρενεργειών.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000695A ITRM20010695A1 (it) | 2001-11-26 | 2001-11-26 | Uso della propionil l-carnitina o di un suo sale farmacologicamente accettabile per la preparazione di un medicamento per il trattamento del |
PCT/IT2002/000745 WO2003045373A1 (en) | 2001-11-26 | 2002-11-26 | Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105347T1 true CY1105347T1 (el) | 2010-03-03 |
Family
ID=11455896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100685T CY1105347T1 (el) | 2001-11-26 | 2006-05-30 | Η χρηση της προπιονυλο l-καρνιτινης ή ενος απο τα φαρμακολογικα αποδεκτα αλατα της για την παρασκευη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της νοσου του peyronie |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050038044A1 (el) |
EP (1) | EP1448184B1 (el) |
JP (1) | JP4370168B2 (el) |
KR (1) | KR100923139B1 (el) |
AT (1) | ATE323481T1 (el) |
AU (1) | AU2002358991A1 (el) |
CA (1) | CA2466135C (el) |
CY (1) | CY1105347T1 (el) |
DE (1) | DE60210804T2 (el) |
DK (1) | DK1448184T3 (el) |
ES (1) | ES2261772T3 (el) |
HU (1) | HUP0402118A3 (el) |
IT (1) | ITRM20010695A1 (el) |
MX (1) | MXPA04004900A (el) |
PL (1) | PL209317B1 (el) |
PT (1) | PT1448184E (el) |
WO (1) | WO2003045373A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8465413B2 (en) | 2010-11-25 | 2013-06-18 | Coloplast A/S | Method of treating Peyronie's disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2658307C2 (de) * | 1976-12-22 | 1979-03-15 | Klinge Pharma Gmbh & Co, 8000 Muenchen | Di-O'-hydroxyphenyD-alkanverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
JPS58501950A (ja) * | 1981-11-18 | 1983-11-17 | ユニリ−バ− ナ−ムロ−ゼ ベンノ−トシヤ−プ | 脂肪の精製 |
US5038633A (en) * | 1989-09-28 | 1991-08-13 | Kabushiki Kaisha Kobe Seiko Sho | Transmission for mini shovel car |
IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
IT1290600B1 (it) * | 1997-04-30 | 1998-12-10 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato |
IT1302858B1 (it) * | 1998-11-11 | 2000-10-10 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento avente attivita' antitumorale. |
-
2001
- 2001-11-26 IT IT2001RM000695A patent/ITRM20010695A1/it unknown
-
2002
- 2002-11-26 KR KR1020047007881A patent/KR100923139B1/ko not_active IP Right Cessation
- 2002-11-26 DE DE60210804T patent/DE60210804T2/de not_active Expired - Lifetime
- 2002-11-26 AU AU2002358991A patent/AU2002358991A1/en not_active Abandoned
- 2002-11-26 PT PT02793337T patent/PT1448184E/pt unknown
- 2002-11-26 PL PL371012A patent/PL209317B1/pl unknown
- 2002-11-26 MX MXPA04004900A patent/MXPA04004900A/es active IP Right Grant
- 2002-11-26 ES ES02793337T patent/ES2261772T3/es not_active Expired - Lifetime
- 2002-11-26 DK DK02793337T patent/DK1448184T3/da active
- 2002-11-26 CA CA2466135A patent/CA2466135C/en not_active Expired - Fee Related
- 2002-11-26 HU HU0402118A patent/HUP0402118A3/hu unknown
- 2002-11-26 US US10/496,659 patent/US20050038044A1/en not_active Abandoned
- 2002-11-26 JP JP2003546875A patent/JP4370168B2/ja not_active Expired - Fee Related
- 2002-11-26 AT AT02793337T patent/ATE323481T1/de active
- 2002-11-26 EP EP02793337A patent/EP1448184B1/en not_active Expired - Lifetime
- 2002-11-26 WO PCT/IT2002/000745 patent/WO2003045373A1/en active IP Right Grant
-
2006
- 2006-05-30 CY CY20061100685T patent/CY1105347T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005511638A (ja) | 2005-04-28 |
ATE323481T1 (de) | 2006-05-15 |
MXPA04004900A (es) | 2004-08-02 |
EP1448184B1 (en) | 2006-04-19 |
DE60210804D1 (de) | 2006-05-24 |
HUP0402118A2 (hu) | 2005-02-28 |
JP4370168B2 (ja) | 2009-11-25 |
PL371012A1 (en) | 2005-06-13 |
CA2466135A1 (en) | 2003-06-05 |
AU2002358991A1 (en) | 2003-06-10 |
HUP0402118A3 (en) | 2012-09-28 |
CA2466135C (en) | 2011-05-31 |
ITRM20010695A0 (it) | 2001-11-26 |
PT1448184E (pt) | 2006-07-31 |
PL209317B1 (pl) | 2011-08-31 |
ES2261772T3 (es) | 2006-11-16 |
US20050038044A1 (en) | 2005-02-17 |
EP1448184A1 (en) | 2004-08-25 |
WO2003045373A1 (en) | 2003-06-05 |
KR20040058316A (ko) | 2004-07-03 |
DK1448184T3 (da) | 2006-08-21 |
ITRM20010695A1 (it) | 2003-05-26 |
KR100923139B1 (ko) | 2009-10-23 |
DE60210804T2 (de) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115417T1 (el) | Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae | |
CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
CY1106283T1 (el) | Κινολινυλ-πυρρολοπυραζολες | |
CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
CY1105407T1 (el) | Αλδονικα οξεα ολιγοσακχαριτων και η τοπικη τους χρηση | |
CY1106521T1 (el) | Αναστολεις τυπου 3 αφυδρογονασης 17βητα-υδροξυστepοειδους για τη θepαπεια ασθενειων που εξαρτωνται απο ανδρογονο | |
CR8352A (es) | Formulaciones farmaceuticas, procedimientos y pautas de dosificacion para el tratamiento y prevencion de sindromes coronarios agudos | |
CY1108070T1 (el) | Παραγωγα κινολινονης, ως αναστολεις κινασης τυροσινης | |
CY1106137T1 (el) | Φαρμακευτικη συνθεση πepιλαμβανουσα λουμιρακοξιμπη | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
CA2503810A1 (en) | Therapeutic agent for fibromyalgia | |
CY1108018T1 (el) | Μεθοδος και φαρμακευτικο σκευασμα για την αντιμετωπιση της αντιστασης στα αντιυπερτασικα φαρμακα και για σχετικες παθησεις | |
EA200400007A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ | |
CY1104977T1 (el) | Χρηση r-αρυλοπροπιονικων οξεων για την παραγωγη φαρμακων πα την αντιμετωπιση παθησεων ρευματικης φυσεως | |
CY1105787T1 (el) | Θepαπευτικη αντιμετωπιση η προληψη της ατροφιας του ουροποιογεννητικου συστηματος και τα συμπτωματα της σε γυναικες | |
CY1109001T1 (el) | Οι καππα-οπιοιδεις αγωνιστες στη θεραπεια των παθησεων της κυστης | |
AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
CY1105165T1 (el) | Φαρμακευτικη συνθεση που πepιλαμβανει συνδυασμο μετφορμινης και 4-οξοβουτανικου οξεος και η χρηση αυτης για τη θepαπεια του διαβητη | |
CY1105347T1 (el) | Η χρηση της προπιονυλο l-καρνιτινης ή ενος απο τα φαρμακολογικα αποδεκτα αλατα της για την παρασκευη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της νοσου του peyronie | |
BRPI0415322A (pt) | composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina | |
NO20032006D0 (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
AR036009A1 (es) | Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica | |
BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος | |
KR900701324A (ko) | 병리학적 혈관 투과성과 조직으로의 혈장 손실의 치료약 |